Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunity elicited by hepatitis C virus

P Farci1, G Orgiana, R H Purcell

  • 1Istituto di Medicina Interna, Università di Cagliari, Italy.

Clinical and Experimental Rheumatology
|November 1, 1995
PubMed
Summary

Hepatitis C virus (HCV) infection often fails to induce protective immunity, hindering vaccine development. Its genetic diversity presents a significant challenge for creating a broadly effective HCV vaccine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiviral properties from plants of the Mediterranean flora.

Natural product research·2015
Same author

The use of molecular assays in the management of viral hepatitis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2008
Same author

Treatment of chronic hepatitis D.

Journal of viral hepatitis·2007
Same author

Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B.

Gut·2006
Same author

The economics of treating chronic hepatitis C patients with peginterferon alpha-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferase.

Journal of viral hepatitis·2006
Same author

A novel germline mutation of MEN 1 gene in a patient with acromegaly and multiple endocrine tumors.

Journal of endocrinological investigation·2005

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis C virus (HCV) is a global health concern, causing chronic liver disease and liver cancer.
  • HCV exhibits significant genetic heterogeneity, complicating infection control and vaccine strategies.

Purpose of the Study:

  • To evaluate the host immune response to Hepatitis C virus (HCV) infection.
  • To assess the potential for developing a broadly protective HCV vaccine.

Main Methods:

  • Review of clinical observations in patients and experimental data from chimpanzee models.
  • Analysis of in vitro and in vivo studies on HCV-induced antibody responses.

Main Results:

  • Most HCV infections lead to chronic disease, indicating immune system failure to clear the virus.
  • Studies show convalescent chimpanzees and re-infected children lack protection against homologous and heterologous HCV strains.
  • While neutralizing antibodies are produced, they are isolate-specific and ineffective against evolving viral variants.

Conclusions:

  • HCV infection generally does not elicit a lasting protective immune response.
  • The genetic diversity of HCV is a primary obstacle to developing a broadly effective vaccine.
  • Further research is needed to overcome HCV's heterogeneity for successful vaccination strategies.

Related Experiment Videos